Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1908000
Max Phase: Preclinical
Molecular Formula: C20H12O
Molecular Weight: 268.31
Molecule Type: Small molecule
Associated Items:
ID: ALA1908000
Max Phase: Preclinical
Molecular Formula: C20H12O
Molecular Weight: 268.31
Molecule Type: Small molecule
Associated Items:
Synonyms (1): 10-Hydroxybenzo[A]Pyrene
Synonyms from Alternative Forms(1):
Canonical SMILES: Oc1cccc2cc3ccc4cccc5ccc(c12)c3c45
Standard InChI: InChI=1S/C20H12O/c21-17-6-2-5-14-11-15-8-7-12-3-1-4-13-9-10-16(19(14)17)20(15)18(12)13/h1-11,21H
Standard InChI Key: ANHMWNGBSJFXSA-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 268.31 | Molecular Weight (Monoisotopic): 268.0888 | AlogP: 5.44 | #Rotatable Bonds: 0 |
Polar Surface Area: 20.23 | Molecular Species: NEUTRAL | HBA: 1 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 1 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 9.43 | CX Basic pKa: | CX LogP: 4.97 | CX LogD: 4.97 |
Aromatic Rings: 5 | Heavy Atoms: 21 | QED Weighted: 0.29 | Np Likeness Score: 0.56 |
1. Tukey RH, Strassburg CP.. (2000) Human UDP-glucuronosyltransferases: metabolism, expression, and disease., 40 (1): [PMID:10836148] [10.1146/annurev.pharmtox.40.1.581] |
Source(1):